Showing results (201-210 of 214) with videos related to
Sort By:
Pageof 22
Journal of Clinical Lipidology|May 4, 2022
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.JACC. Cardiovascular Imaging|November 26, 2022
Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR TrialTomoko Negishi, Paaladinesh Thavendiranathan, Martin Penicka, et al.Lancet (London, England)|March 26, 2011
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation studyMartin Than, Louise Cullen, Christopher M Reid, et al.Current Vascular Pharmacology|November 9, 2021
Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of IndiaRaman Puri, Vimal Mehta, Shamanna Seshadri Iyengar, et al.The Journal of the Association of Physicians of India|September 9, 2022
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic AcidVimal Mehta, Raman Puri, P Barton Duell, et al.The Journal of the Association of Physicians of India|October 11, 2024
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of IndiaRaman Puri, Vimal Mehta, Manish Bansal, et al.Journal of Clinical Lipidology|March 14, 2024
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IVRaman Puri, Manish Bansal, Vimal Mehta, et al.The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22nd May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.Pageof 22